Justin W. Yorke, Director at Processa Pharmaceuticals, Inc. (PCSA), bought 12,400 shares at $0.80 ($10K) on 2025-01-27, disclosed to the SEC on 2025-01-31.
Seasonal purchase ($10k) by Director — this insider has traded PCSA in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| PCSA | SELL | 2021-12-07 | $46K | — | Filing → |
| PCSA | SELL | 2021-04-15 | $220K | — | Filing → |